SlideShare a Scribd company logo
Rhabdomyolysis
Form Pathogenesis to Bedside
Mohammed Abdel Gawad
Nephrology Specialist
Kidney & Urology Center (KUC)
Alexandria - EGY
drgawad@gmail.com
AKI Workshop – Ras El Bar – Feb 2015
To download the lecture with full
animation please contact me on
drgawad@gmail.com
Bywaters EG, Beall D. Br Med J. 1941;1:427-432.
During bombing of London in World War II
Pathogenesis / Causes
Rhabdomyolysis
Traumatic Non Traumatic
Pathogenesis / Causes
Rhabdomyolysis
Traumatic Non Traumatic
Traumatic - Rhabdomyolysis
Myoglobin
Na
Ca
MyocyteCell
CK, LDH
Purines
Electrolytes (esp. K + and PO4)
Aminotransferase enzymes
Lactate
Serum
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
Traumatic - Rhabdomyolysis
Myoglobin
Na
Ca
MyocyteCell
CK, LDH
Purines
Electrolytes (esp. K + and PO4)
Aminotransferase enzymes
Lactate
Serum
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
Traumatic - Rhabdomyolysis
Myoglobin
Na
Ca
MyocyteCell
CK, LDH
Purines
Electrolytes (esp. K + and PO4)
Aminotransferase enzymes
Lactate
Serum
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
Traumatic - Rhabdomyolysis
Myoglobin
Na
Ca
MyocyteCell
CK, LDH
Purines
Electrolytes (esp. K + and PO4)
Aminotransferase enzymes
Lactate
Serum
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
→ Uric Acid
MyocyteCellSerum
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
→ Uric Acid
MyocyteCellSerum
H2O
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
?? AKI
Traumatic - Rhabdomyolysis
ATN
Pathogenesis
Rhabdomyolysis
Traumatic Non Traumatic
Pathogenesis
Rhabdomyolysis
Traumatic Non Traumatic
Non Traumatic - Rhabdomyolysis
MyocyteCellSerum
Sarcoplasmic
Reticulum (Ca
Store)
Intracellular Contents
Na
Ca
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
Non Traumatic - Rhabdomyolysis
MyocyteCellSerum
Sarcoplasmic
Reticulum (Ca
Store)
Na-K ATPase
Pump
Ca ATPase
Pump
Ca
ATPase
Pump
Intracellular Contents
Na
Ca
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
Non Traumatic - Rhabdomyolysis
MyocyteCellSerum
Sarcoplasmic
Reticulum (Ca
Store)
Na-K ATPase
Pump
Ca ATPase
Pump
Ca
ATPase
Pump
Depletion of ATP
Disturbance of
ATPase function
↑ Intracellular &
Mitochondrial Ca
Intracellular Contents
Na
Ca
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
Non Traumatic - Rhabdomyolysis
MyocyteCellSerum
Sarcoplasmic
Reticulum (Ca
Store)
Ca
ATPase
Pump
Depletion of ATP
Disturbance of
ATPase function
↑ Intracellular &
Mitochondrial Ca
↑ Intracellular Ca
→ increased skeletal muscle
cell contractility and the
production of ROS → skeletal
muscle cell death
Intracellular Contents
Na
Ca
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
Non Traumatic - Rhabdomyolysis
MyocyteCellSerum
Sarcoplasmic
Reticulum (Ca
Store)
Ca
ATPase
Pump
Depletion of ATP
Disturbance of
ATPase function
↑ Intracellular &
Mitochondrial Ca
↑ Intracellular Ca
→ increased skeletal muscle
cell contractility and the
production of ROS → skeletal
muscle cell death
Intracellular Contents
Na
Ca
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
Non Traumatic - Rhabdomyolysis
MyocyteCellSerum
Sarcoplasmic
Reticulum (Ca
Store)
Ca
ATPase
Pump
Depletion of ATP
Disturbance of
ATPase function
↑ Intracellular &
Mitochondrial Ca
↑ Intracellular Ca
→ increased skeletal muscle
cell contractility and the
production of ROS → skeletal
muscle cell death
Intracellular Contents
Na
Ca
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
Pathogenesis - Rhabdomyolysis
Rhabdomyolysis
Traumatic Non Traumatic
When to Suspect?
Clinical Presentation & Lab Ix
ATN
ATN
When to Suspect?
Clinical Presentation & Lab Ix
• The reported frequency of AKI ranges from 15 to over
50 percent
• CK < 20,000 U/l → lower risk of AKI
• CK levels 5000 U/l + coexisting conditions (sepsis,
intravascular volume contraction, acidosis) → AKI risk
increases.
Melli G. Medicine (Baltimore). 2005 Nov;84(6):377-85.
Bosch X. N Engl J Med. 2009 Jul 2;361(1):62-72.
Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
When to Suspect?
Clinical Presentation & Lab Ix
ATN
ATN
When to Suspect?
Clinical Presentation & Lab Ix
Myoglobin excreted in urine
Dark, reddish-brown urine
(+ve dipstick)
-ve microscopic evaluation of
the urine for RBCs
(less than five per high-powered field) - Sanders PW, Agarwal A. In: Nabel EG, ed. ACP Medicine, A Textbook
of Medicine. Hamilton, Canada: Decker Intellectual Properties; 2010.
- Huerta-Alardín AL. Crit Care. 2005 Apr;9(2):158-69. Epub 2004 Oct 20
- Giannoglou GD. Eur J Intern Med. 2007 Mar;18(2):90-100.
ATN
When to Suspect?
Clinical Presentation & Lab Ix
Myoglobin excreted in urine
Dark, reddish-brown urine
(+ve dipstick)
-ve microscopic evaluation of
the urine for RBCs
(less than five per high-powered field)
Routine urine testing
for myoglobin by urine
dipstick evaluation
may be negative in up
to 50% of patients
with rhabdomyolysis
• Myoglobin appears in the urine
when the plasma concentration
exceeds 1.5 mg/dL
• Myoglobin has a short half-life of
only 2-3 hours
• A suggested role for extrarenal
metabolism and clearance of
myoglobin
Giannoglou GD. Eur J Intern Med. 2007 Mar;18(2):90-100.
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
Wakabayashi Y. Intensive Care Med. 1994;20(2):109-12.
When to Suspect?
Clinical Presentation & Lab Ix
ATN
ATN
When to Suspect?
Clinical Presentation & Lab Ix
Giannoglou GD. Eur J Intern Med. 2007 Mar;18(2):90-100.
Gabow PA. Medicine (Baltimore). 1982 May;61(3):141-52.
However, more than half of patients may
not report muscular symptoms
Muscle pain, Weakness
When to Suspect?
Clinical Presentation & Lab Ix
ATN
ATN
When to Suspect?
Clinical Presentation & Lab Ix
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
ATN
When to Suspect?
Clinical Presentation & Lab Ix
Serum Level:
1500 to over 100,000 IU/L
Type:
Mainly
CK-MM,
Small
amount
CK-MB 2 -12
hours
after
injury
24 -72
hours
after
injury
3-5 days
after
injury
cessation
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
ATN
When to Suspect?
Clinical Presentation & Lab Ix
Serum Level:
1500 to over 100,000 IU/L
Type:
Mainly
CK-MM,
Small
amount
CK-MB 2 -12
hours
after
injury
24 -72
hours
after
injury
3-5 days
after
injury
cessation
CK serum half-life
= 1.5 days
declines 40 to 50 % of
the previous day’s value
If CK does not decline
as expected
= continued muscle
injury or the
development of a
compartment
syndrome
Khan FY. Neth J Med. 2009 Oct;67(9):272-83
MyocyteCell
CK, LDH
Purines
Electrolytes (esp. K + and PO4)
Aminotransferase enzymes
Lactate
Myoglobin
Serum When to Suspect?
Clinical Presentation & Lab Ix
Thromboplastin +
other prothrombotic
substances
Chatzizisis YS. Eur J Intern Med. 2008 Dec;19(8):568-74
MyocyteCell
CK, LDH
Purines
Electrolytes (esp. K + and PO4)
Aminotransferase enzymes
Lactate
Myoglobin
Serum When to Suspect?
Clinical Presentation & Lab Ix
Thromboplastin +
other prothrombotic
substances
DIC
(infrequent complication)
Chatzizisis YS. Eur J Intern Med. 2008 Dec;19(8):568-74
Management
Volume replacement
(hydration)
1
Bicarbonate
Infusion !!!
2
Mannitol
Infusion !!!
3
ATN
Management
Hypocalcemia !!!4
Hyperuricemia (Allopurinol)5
Hyperkalemia
management
6
Dialysis
(when indicated)
7
Volume Replacement (Hydration)
• What? Isotonic saline
• Target? UOP should be maintained around
200-300 ml/h
• Continued until
–plasma CK levels decrease to <5000 unit/L
–urine is dipstick negative for hematuria
1
Hatamizadeh P. Am J Kidney Dis. 2006 Mar;47(3):428-38.
Sever MS, Vanholder R. Clin J Am Soc Nephrol.2013;8:328-335.
Volume Replacement (Hydration)1
Paletta CE. Ann Plast Surg. 1993 Mar;30(3):272-3.
Carefully assess:
Volume status, UOP
(Take care of HYPERVOLEMIA)
Compartment syndrome may develop after
fluid resuscitation, with worsening edema of
the limb and muscle
Bicarbonate Infusion2
To Whom?
CK > 5000 / Sever injury, providing the following conditions are met:
●Severe hypocalcemia is not present
●Arterial pH is <7.5 ●Serum HCO3 < 30 mEq/L
How?
- Infuse 150 mL of 8.4 % NaHCO3
mixed with 1 L of 5 % dextrose
(alternating with isotonic saline)
- The initial rate of infusion is
200 mL/hour
- the rate is adjusted to achieve
a urine pH of >6.5.
When to stop?
1- symptomatic hypocalcemia
2-arterial pH > 7.5
3-serum bicarbonate >
30 mEq/L.
4-urine pH does not rise
above 6.5 after 3-4 hrs
Monitor
art pH &
Ca / 2hrs
Melli G. Medicine (Baltimore). 2005 Nov;84(6):377-85.
Mannitol Infusion3
To Whom?
Urinary flow is adequate (defined as >20 mL/hour)
Patients with extremely high serum CK levels (greater than
30,000 unit/L) Brown CV. J Trauma. 2004 Jun;56(6):1191-6.
How?
given at a rate of 5 g/h
added to each liter of
infusate and not exceeding
1 to 2 g/kg/day.
When to stop?
1- osmolal gap rises above
55 mosmol/kg
2- diuresis of 200 to
300 mL/hour cannot be
achieved
(increased risk of
hyperosmolality, volume
overload, and hyperkalemia )
Sever MS, Vanholder R, Lameire N. N Engl J Med. 2006;354:1052-1063.
Evidence !!!
The evidence for the
effectiveness of
NaHCO3 infusion &
Mannitol is very weak
Hypocalcemia4
Give Ca supplement ONLY IF:
1- Symptomatic hypocalcemia
2- Management of hyperkalemia
Why?
During the recovery phase:
Release of calcium from injured muscle → serum Ca levels
return to normal and may rebound to significantly elevated
levels
Akmal M. J Clin Endocrinol Metab. 1986 Jul;63(1):137-42.
Treat the cause
• The specific cause is frequently evident from
the history or from the immediate
circumstances preceding the disorder.
• Consider toxicology screen for drugs, viral
screen, TSH if cause not apparent.
PROGNOSIS
The overall prognosis for patients with heme-
induced AKI is favorable as most survivors recover
sufficient kidney function to be dialysis
independent, and many will recover to normal or
near-normal kidney function
Woodrow G. Ren Fail. 1995 Jul;17(4):467-74.
• Rhabdomyolysis may be traumatic or non traumatic
• Final common pathway of pathogenesis is the leak of
intramuscular contents into circulation
• Final common pathway is sequestration of Ca & H2O
into muscles
• Hallmark of AKI is ATN
• Dipstick may be –ve for myglobinuria
• Muscle pain may be absent
• Re-rise of CK = Compartment syndrome or metabolic
disorder
• Corner stone of management is hydration
• NaHCO3 = Precautions = Weak evidence
• Mannitol = Precautions = Weak evidence
• Ca supplement = Precautions
• Prognosis is good
Mohammed Abdel Gawad
Thank You

More Related Content

What's hot

Hyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. GawadHyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Budd chiari syndrome. ppt
Budd chiari syndrome. pptBudd chiari syndrome. ppt
Budd chiari syndrome. ppt
Dr Amit Dangi
 
Anaemia of chronic kidney disease GUIDELINES TO PRACTICE 2013
Anaemia of chronic kidney disease GUIDELINES TO PRACTICE  2013Anaemia of chronic kidney disease GUIDELINES TO PRACTICE  2013
Anaemia of chronic kidney disease GUIDELINES TO PRACTICE 2013
Ayman Seddik
 
Acute Hyperkalemia Management - Dr. Gawad
Acute Hyperkalemia Management - Dr. Gawad Acute Hyperkalemia Management - Dr. Gawad
Acute Hyperkalemia Management - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
NephroTube - Dr.Gawad
 
Rhabdomyolysis .-dr.-osama-2017
Rhabdomyolysis .-dr.-osama-2017Rhabdomyolysis .-dr.-osama-2017
Rhabdomyolysis .-dr.-osama-2017
FarragBahbah
 
Intra dialytic hypotension ,,, prof Alaa Sabry
Intra dialytic hypotension ,,,  prof Alaa SabryIntra dialytic hypotension ,,,  prof Alaa Sabry
Intra dialytic hypotension ,,, prof Alaa Sabry
FarragBahbah
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Dialyisis disequilibrium syndrome
Dialyisis disequilibrium syndromeDialyisis disequilibrium syndrome
Dialyisis disequilibrium syndrome
saihari17
 
Ckd mbd guideline
Ckd mbd guidelineCkd mbd guideline
Ckd mbd guideline
drsam123
 
Major Acute Hemodialysis Complications - Hoping to Prevent - Dr. Gawad
Major Acute Hemodialysis Complications - Hoping to Prevent - Dr. GawadMajor Acute Hemodialysis Complications - Hoping to Prevent - Dr. Gawad
Major Acute Hemodialysis Complications - Hoping to Prevent - Dr. Gawad
NephroTube - Dr.Gawad
 
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
NephroTube - Dr.Gawad
 
Spotlight on indication of dialysis
Spotlight on indication of dialysisSpotlight on indication of dialysis
Spotlight on indication of dialysis
mohamed hassan abbass
 
AKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. GawadAKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. Gawad
NephroTube - Dr.Gawad
 
Anemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of viewAnemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of view
MNDU net
 
Fluid Therapy In AKI
Fluid Therapy In AKI Fluid Therapy In AKI
Fluid Therapy In AKI
MNDU net
 
Renal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidenceRenal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidence
Mohd Saif Khan
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
MNDU net
 
Contrast induced AKI
Contrast induced AKIContrast induced AKI
Contrast induced AKI
Amit Gulati
 
CKD BMD
CKD BMDCKD BMD
CKD BMD
FarragBahbah
 

What's hot (20)

Hyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. GawadHyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. Gawad
 
Budd chiari syndrome. ppt
Budd chiari syndrome. pptBudd chiari syndrome. ppt
Budd chiari syndrome. ppt
 
Anaemia of chronic kidney disease GUIDELINES TO PRACTICE 2013
Anaemia of chronic kidney disease GUIDELINES TO PRACTICE  2013Anaemia of chronic kidney disease GUIDELINES TO PRACTICE  2013
Anaemia of chronic kidney disease GUIDELINES TO PRACTICE 2013
 
Acute Hyperkalemia Management - Dr. Gawad
Acute Hyperkalemia Management - Dr. Gawad Acute Hyperkalemia Management - Dr. Gawad
Acute Hyperkalemia Management - Dr. Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
 
Rhabdomyolysis .-dr.-osama-2017
Rhabdomyolysis .-dr.-osama-2017Rhabdomyolysis .-dr.-osama-2017
Rhabdomyolysis .-dr.-osama-2017
 
Intra dialytic hypotension ,,, prof Alaa Sabry
Intra dialytic hypotension ,,,  prof Alaa SabryIntra dialytic hypotension ,,,  prof Alaa Sabry
Intra dialytic hypotension ,,, prof Alaa Sabry
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
 
Dialyisis disequilibrium syndrome
Dialyisis disequilibrium syndromeDialyisis disequilibrium syndrome
Dialyisis disequilibrium syndrome
 
Ckd mbd guideline
Ckd mbd guidelineCkd mbd guideline
Ckd mbd guideline
 
Major Acute Hemodialysis Complications - Hoping to Prevent - Dr. Gawad
Major Acute Hemodialysis Complications - Hoping to Prevent - Dr. GawadMajor Acute Hemodialysis Complications - Hoping to Prevent - Dr. Gawad
Major Acute Hemodialysis Complications - Hoping to Prevent - Dr. Gawad
 
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
 
Spotlight on indication of dialysis
Spotlight on indication of dialysisSpotlight on indication of dialysis
Spotlight on indication of dialysis
 
AKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. GawadAKI in Sepsis - Dr. Gawad
AKI in Sepsis - Dr. Gawad
 
Anemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of viewAnemia in CKD:Clinical point of view
Anemia in CKD:Clinical point of view
 
Fluid Therapy In AKI
Fluid Therapy In AKI Fluid Therapy In AKI
Fluid Therapy In AKI
 
Renal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidenceRenal Replacement Therapy: modes and evidence
Renal Replacement Therapy: modes and evidence
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
 
Contrast induced AKI
Contrast induced AKIContrast induced AKI
Contrast induced AKI
 
CKD BMD
CKD BMDCKD BMD
CKD BMD
 

Viewers also liked

Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
Jamie Ranse
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
fathi neana
 
Rhabdomyolysis -Registar teaching (9-10-12)b
Rhabdomyolysis -Registar teaching (9-10-12)bRhabdomyolysis -Registar teaching (9-10-12)b
Rhabdomyolysis -Registar teaching (9-10-12)b
Bishan Rajapakse
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
rajkumarsrihari
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
Wahid altaf Sheeba hakak
 
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. GawadDiabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
NephroTube - Dr.Gawad
 
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
NephroTube - Dr.Gawad
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
NephroTube - Dr.Gawad
 
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. GawadUremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
NephroTube - Dr.Gawad
 
How to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. GawadHow to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. Gawad
NephroTube - Dr.Gawad
 
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
NephroTube - Dr.Gawad
 
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
NephroTube - Dr.Gawad
 
Crush injuries and rhabdomyolysis
Crush injuries and rhabdomyolysisCrush injuries and rhabdomyolysis
Crush injuries and rhabdomyolysis
djorgenmorris
 
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
NephroTube - Dr.Gawad
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. GawadInfection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
NephroTube - Dr.Gawad
 
Membranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. GawadMembranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. Gawad
NephroTube - Dr.Gawad
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
NephroTube - Dr.Gawad
 

Viewers also liked (20)

Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
 
rhabdomyolysis 2016
rhabdomyolysis 2016rhabdomyolysis 2016
rhabdomyolysis 2016
 
Rhabdomyolysis -Registar teaching (9-10-12)b
Rhabdomyolysis -Registar teaching (9-10-12)bRhabdomyolysis -Registar teaching (9-10-12)b
Rhabdomyolysis -Registar teaching (9-10-12)b
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
 
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. GawadDiabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
Diabetes Mellitus Management - علاج داء السكري (Nursing Program) - Dr. Gawad
 
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
Plasma Cell Dyscrasias & The Kidney (Brainstorming The Concept - Nephrology P...
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
 
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. GawadUremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
 
How to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. GawadHow to examine AVF in 10 minutes - Dr. Gawad
How to examine AVF in 10 minutes - Dr. Gawad
 
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
Anti-Phospholipase A2 Receptor Antibody - Clinical Application for Membranous...
 
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
 
Crush injuries and rhabdomyolysis
Crush injuries and rhabdomyolysisCrush injuries and rhabdomyolysis
Crush injuries and rhabdomyolysis
 
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
 
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. GawadLupus Nephritis Management (The Soft Evidence) - Dr. Gawad
Lupus Nephritis Management (The Soft Evidence) - Dr. Gawad
 
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. GawadInfection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
 
Membranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. GawadMembranous Nephropathy - Management Algorithm - Dr. Gawad
Membranous Nephropathy - Management Algorithm - Dr. Gawad
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 

Similar to Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad

POTTASIUM METABOLISM & APPROACH TO HYPERKALEMIA
POTTASIUM METABOLISM & APPROACH TO HYPERKALEMIAPOTTASIUM METABOLISM & APPROACH TO HYPERKALEMIA
POTTASIUM METABOLISM & APPROACH TO HYPERKALEMIA
Manoj Prabhakar
 
Approach to Hyperkalemia
Approach to HyperkalemiaApproach to Hyperkalemia
Approach to Hyperkalemia
Ravi Kumar
 
PTH - Chronic Renal Failure
PTH - Chronic Renal FailurePTH - Chronic Renal Failure
PTH - Chronic Renal Failure
Andre Garcia
 
Lactic Acidosis
Lactic AcidosisLactic Acidosis
Lactic Acidosis
Wisit Cheungpasitporn
 
Biochemical changes in stored blood
Biochemical changes in stored bloodBiochemical changes in stored blood
Biochemical changes in stored blood
Moustafa Rezk
 
attacheedadeda_20200303225554891008.pptx
attacheedadeda_20200303225554891008.pptxattacheedadeda_20200303225554891008.pptx
attacheedadeda_20200303225554891008.pptx
akiko46
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionAndrew Ferguson
 
Aki Rhabdomyolysis
Aki RhabdomyolysisAki Rhabdomyolysis
Aki Rhabdomyolysis
Adrianne Gabucan
 
Update on fluid therapy in dhf
Update on fluid therapy in dhfUpdate on fluid therapy in dhf
Update on fluid therapy in dhf
Dr Iyan Darmawan
 
Fluid sepsis ny_2013a
Fluid sepsis ny_2013aFluid sepsis ny_2013a
Fluid sepsis ny_2013a
EMCrit Blog and Podcast
 
CHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURE
CHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURECHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURE
CHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURE
MohmmadRjab Seder
 
shock marker
shock markershock marker
shock markerEM OMSB
 
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Cleveland HeartLab, Inc.
 
Serum Potassium .pptx
Serum Potassium .pptxSerum Potassium .pptx
Serum Potassium .pptx
sanaiqbal52
 
Fluid management in icu dr vijay
Fluid management in icu dr vijayFluid management in icu dr vijay
Fluid management in icu dr vijay
Vijay Kumar
 
Intensive care nephrology
Intensive care nephrologyIntensive care nephrology
Intensive care nephrology
FarragBahbah
 
1618256660403_hypokalemia and hyperkalemia.pptx
1618256660403_hypokalemia and hyperkalemia.pptx1618256660403_hypokalemia and hyperkalemia.pptx
1618256660403_hypokalemia and hyperkalemia.pptx
VignesKm1
 
Concept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practiceConcept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practiceDr. MD. Majedul Islam
 
Hypokalemia in ICU
Hypokalemia in ICUHypokalemia in ICU
Hypokalemia in ICU
Muhammad Asim Rana
 
A new perspective on hypocalcemia
A new perspective on hypocalcemiaA new perspective on hypocalcemia
A new perspective on hypocalcemia
stevechendoc
 

Similar to Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad (20)

POTTASIUM METABOLISM & APPROACH TO HYPERKALEMIA
POTTASIUM METABOLISM & APPROACH TO HYPERKALEMIAPOTTASIUM METABOLISM & APPROACH TO HYPERKALEMIA
POTTASIUM METABOLISM & APPROACH TO HYPERKALEMIA
 
Approach to Hyperkalemia
Approach to HyperkalemiaApproach to Hyperkalemia
Approach to Hyperkalemia
 
PTH - Chronic Renal Failure
PTH - Chronic Renal FailurePTH - Chronic Renal Failure
PTH - Chronic Renal Failure
 
Lactic Acidosis
Lactic AcidosisLactic Acidosis
Lactic Acidosis
 
Biochemical changes in stored blood
Biochemical changes in stored bloodBiochemical changes in stored blood
Biochemical changes in stored blood
 
attacheedadeda_20200303225554891008.pptx
attacheedadeda_20200303225554891008.pptxattacheedadeda_20200303225554891008.pptx
attacheedadeda_20200303225554891008.pptx
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive Transfusion
 
Aki Rhabdomyolysis
Aki RhabdomyolysisAki Rhabdomyolysis
Aki Rhabdomyolysis
 
Update on fluid therapy in dhf
Update on fluid therapy in dhfUpdate on fluid therapy in dhf
Update on fluid therapy in dhf
 
Fluid sepsis ny_2013a
Fluid sepsis ny_2013aFluid sepsis ny_2013a
Fluid sepsis ny_2013a
 
CHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURE
CHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURECHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURE
CHRONIC KIDNEY DISEASE & END STAGE RENAL FAILURE
 
shock marker
shock markershock marker
shock marker
 
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
 
Serum Potassium .pptx
Serum Potassium .pptxSerum Potassium .pptx
Serum Potassium .pptx
 
Fluid management in icu dr vijay
Fluid management in icu dr vijayFluid management in icu dr vijay
Fluid management in icu dr vijay
 
Intensive care nephrology
Intensive care nephrologyIntensive care nephrology
Intensive care nephrology
 
1618256660403_hypokalemia and hyperkalemia.pptx
1618256660403_hypokalemia and hyperkalemia.pptx1618256660403_hypokalemia and hyperkalemia.pptx
1618256660403_hypokalemia and hyperkalemia.pptx
 
Concept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practiceConcept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practice
 
Hypokalemia in ICU
Hypokalemia in ICUHypokalemia in ICU
Hypokalemia in ICU
 
A new perspective on hypocalcemia
A new perspective on hypocalcemiaA new perspective on hypocalcemia
A new perspective on hypocalcemia
 

More from NephroTube - Dr.Gawad

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
NephroTube - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
NephroTube - Dr.Gawad
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
NephroTube - Dr.Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
NephroTube - Dr.Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
NephroTube - Dr.Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
NephroTube - Dr.Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
NephroTube - Dr.Gawad
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
NephroTube - Dr.Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
NephroTube - Dr.Gawad
 

More from NephroTube - Dr.Gawad (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
 

Recently uploaded

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 

Recently uploaded (20)

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 

Rhabdomyolysis - Form Pathogenesis to Bedside - Dr. Gawad

  • 1. Rhabdomyolysis Form Pathogenesis to Bedside Mohammed Abdel Gawad Nephrology Specialist Kidney & Urology Center (KUC) Alexandria - EGY drgawad@gmail.com AKI Workshop – Ras El Bar – Feb 2015
  • 2. To download the lecture with full animation please contact me on drgawad@gmail.com
  • 3. Bywaters EG, Beall D. Br Med J. 1941;1:427-432. During bombing of London in World War II
  • 6. Traumatic - Rhabdomyolysis Myoglobin Na Ca MyocyteCell CK, LDH Purines Electrolytes (esp. K + and PO4) Aminotransferase enzymes Lactate Serum Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 7. Traumatic - Rhabdomyolysis Myoglobin Na Ca MyocyteCell CK, LDH Purines Electrolytes (esp. K + and PO4) Aminotransferase enzymes Lactate Serum Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 8. Traumatic - Rhabdomyolysis Myoglobin Na Ca MyocyteCell CK, LDH Purines Electrolytes (esp. K + and PO4) Aminotransferase enzymes Lactate Serum Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 9. Traumatic - Rhabdomyolysis Myoglobin Na Ca MyocyteCell CK, LDH Purines Electrolytes (esp. K + and PO4) Aminotransferase enzymes Lactate Serum Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 10. → Uric Acid MyocyteCellSerum Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 11. → Uric Acid MyocyteCellSerum H2O Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 12. Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 13.
  • 16. ATN
  • 19. Non Traumatic - Rhabdomyolysis MyocyteCellSerum Sarcoplasmic Reticulum (Ca Store) Intracellular Contents Na Ca Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 20. Non Traumatic - Rhabdomyolysis MyocyteCellSerum Sarcoplasmic Reticulum (Ca Store) Na-K ATPase Pump Ca ATPase Pump Ca ATPase Pump Intracellular Contents Na Ca Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 21. Non Traumatic - Rhabdomyolysis MyocyteCellSerum Sarcoplasmic Reticulum (Ca Store) Na-K ATPase Pump Ca ATPase Pump Ca ATPase Pump Depletion of ATP Disturbance of ATPase function ↑ Intracellular & Mitochondrial Ca Intracellular Contents Na Ca Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 22. Non Traumatic - Rhabdomyolysis MyocyteCellSerum Sarcoplasmic Reticulum (Ca Store) Ca ATPase Pump Depletion of ATP Disturbance of ATPase function ↑ Intracellular & Mitochondrial Ca ↑ Intracellular Ca → increased skeletal muscle cell contractility and the production of ROS → skeletal muscle cell death Intracellular Contents Na Ca Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 23. Non Traumatic - Rhabdomyolysis MyocyteCellSerum Sarcoplasmic Reticulum (Ca Store) Ca ATPase Pump Depletion of ATP Disturbance of ATPase function ↑ Intracellular & Mitochondrial Ca ↑ Intracellular Ca → increased skeletal muscle cell contractility and the production of ROS → skeletal muscle cell death Intracellular Contents Na Ca Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 24. Non Traumatic - Rhabdomyolysis MyocyteCellSerum Sarcoplasmic Reticulum (Ca Store) Ca ATPase Pump Depletion of ATP Disturbance of ATPase function ↑ Intracellular & Mitochondrial Ca ↑ Intracellular Ca → increased skeletal muscle cell contractility and the production of ROS → skeletal muscle cell death Intracellular Contents Na Ca Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 26. When to Suspect? Clinical Presentation & Lab Ix ATN
  • 27. ATN When to Suspect? Clinical Presentation & Lab Ix • The reported frequency of AKI ranges from 15 to over 50 percent • CK < 20,000 U/l → lower risk of AKI • CK levels 5000 U/l + coexisting conditions (sepsis, intravascular volume contraction, acidosis) → AKI risk increases. Melli G. Medicine (Baltimore). 2005 Nov;84(6):377-85. Bosch X. N Engl J Med. 2009 Jul 2;361(1):62-72. Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62-72.
  • 28. When to Suspect? Clinical Presentation & Lab Ix ATN
  • 29. ATN When to Suspect? Clinical Presentation & Lab Ix Myoglobin excreted in urine Dark, reddish-brown urine (+ve dipstick) -ve microscopic evaluation of the urine for RBCs (less than five per high-powered field) - Sanders PW, Agarwal A. In: Nabel EG, ed. ACP Medicine, A Textbook of Medicine. Hamilton, Canada: Decker Intellectual Properties; 2010. - Huerta-Alardín AL. Crit Care. 2005 Apr;9(2):158-69. Epub 2004 Oct 20 - Giannoglou GD. Eur J Intern Med. 2007 Mar;18(2):90-100.
  • 30. ATN When to Suspect? Clinical Presentation & Lab Ix Myoglobin excreted in urine Dark, reddish-brown urine (+ve dipstick) -ve microscopic evaluation of the urine for RBCs (less than five per high-powered field) Routine urine testing for myoglobin by urine dipstick evaluation may be negative in up to 50% of patients with rhabdomyolysis • Myoglobin appears in the urine when the plasma concentration exceeds 1.5 mg/dL • Myoglobin has a short half-life of only 2-3 hours • A suggested role for extrarenal metabolism and clearance of myoglobin Giannoglou GD. Eur J Intern Med. 2007 Mar;18(2):90-100. Khan FY. Neth J Med. 2009 Oct;67(9):272-83 Wakabayashi Y. Intensive Care Med. 1994;20(2):109-12.
  • 31. When to Suspect? Clinical Presentation & Lab Ix ATN
  • 32. ATN When to Suspect? Clinical Presentation & Lab Ix Giannoglou GD. Eur J Intern Med. 2007 Mar;18(2):90-100. Gabow PA. Medicine (Baltimore). 1982 May;61(3):141-52. However, more than half of patients may not report muscular symptoms Muscle pain, Weakness
  • 33. When to Suspect? Clinical Presentation & Lab Ix ATN
  • 34. ATN When to Suspect? Clinical Presentation & Lab Ix Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 35. ATN When to Suspect? Clinical Presentation & Lab Ix Serum Level: 1500 to over 100,000 IU/L Type: Mainly CK-MM, Small amount CK-MB 2 -12 hours after injury 24 -72 hours after injury 3-5 days after injury cessation Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 36. ATN When to Suspect? Clinical Presentation & Lab Ix Serum Level: 1500 to over 100,000 IU/L Type: Mainly CK-MM, Small amount CK-MB 2 -12 hours after injury 24 -72 hours after injury 3-5 days after injury cessation CK serum half-life = 1.5 days declines 40 to 50 % of the previous day’s value If CK does not decline as expected = continued muscle injury or the development of a compartment syndrome Khan FY. Neth J Med. 2009 Oct;67(9):272-83
  • 37. MyocyteCell CK, LDH Purines Electrolytes (esp. K + and PO4) Aminotransferase enzymes Lactate Myoglobin Serum When to Suspect? Clinical Presentation & Lab Ix Thromboplastin + other prothrombotic substances Chatzizisis YS. Eur J Intern Med. 2008 Dec;19(8):568-74
  • 38. MyocyteCell CK, LDH Purines Electrolytes (esp. K + and PO4) Aminotransferase enzymes Lactate Myoglobin Serum When to Suspect? Clinical Presentation & Lab Ix Thromboplastin + other prothrombotic substances DIC (infrequent complication) Chatzizisis YS. Eur J Intern Med. 2008 Dec;19(8):568-74
  • 41. Volume Replacement (Hydration) • What? Isotonic saline • Target? UOP should be maintained around 200-300 ml/h • Continued until –plasma CK levels decrease to <5000 unit/L –urine is dipstick negative for hematuria 1 Hatamizadeh P. Am J Kidney Dis. 2006 Mar;47(3):428-38. Sever MS, Vanholder R. Clin J Am Soc Nephrol.2013;8:328-335.
  • 42. Volume Replacement (Hydration)1 Paletta CE. Ann Plast Surg. 1993 Mar;30(3):272-3. Carefully assess: Volume status, UOP (Take care of HYPERVOLEMIA) Compartment syndrome may develop after fluid resuscitation, with worsening edema of the limb and muscle
  • 43. Bicarbonate Infusion2 To Whom? CK > 5000 / Sever injury, providing the following conditions are met: ●Severe hypocalcemia is not present ●Arterial pH is <7.5 ●Serum HCO3 < 30 mEq/L How? - Infuse 150 mL of 8.4 % NaHCO3 mixed with 1 L of 5 % dextrose (alternating with isotonic saline) - The initial rate of infusion is 200 mL/hour - the rate is adjusted to achieve a urine pH of >6.5. When to stop? 1- symptomatic hypocalcemia 2-arterial pH > 7.5 3-serum bicarbonate > 30 mEq/L. 4-urine pH does not rise above 6.5 after 3-4 hrs Monitor art pH & Ca / 2hrs Melli G. Medicine (Baltimore). 2005 Nov;84(6):377-85.
  • 44. Mannitol Infusion3 To Whom? Urinary flow is adequate (defined as >20 mL/hour) Patients with extremely high serum CK levels (greater than 30,000 unit/L) Brown CV. J Trauma. 2004 Jun;56(6):1191-6. How? given at a rate of 5 g/h added to each liter of infusate and not exceeding 1 to 2 g/kg/day. When to stop? 1- osmolal gap rises above 55 mosmol/kg 2- diuresis of 200 to 300 mL/hour cannot be achieved (increased risk of hyperosmolality, volume overload, and hyperkalemia ) Sever MS, Vanholder R, Lameire N. N Engl J Med. 2006;354:1052-1063.
  • 45. Evidence !!! The evidence for the effectiveness of NaHCO3 infusion & Mannitol is very weak
  • 46. Hypocalcemia4 Give Ca supplement ONLY IF: 1- Symptomatic hypocalcemia 2- Management of hyperkalemia Why? During the recovery phase: Release of calcium from injured muscle → serum Ca levels return to normal and may rebound to significantly elevated levels Akmal M. J Clin Endocrinol Metab. 1986 Jul;63(1):137-42.
  • 47. Treat the cause • The specific cause is frequently evident from the history or from the immediate circumstances preceding the disorder. • Consider toxicology screen for drugs, viral screen, TSH if cause not apparent.
  • 48. PROGNOSIS The overall prognosis for patients with heme- induced AKI is favorable as most survivors recover sufficient kidney function to be dialysis independent, and many will recover to normal or near-normal kidney function Woodrow G. Ren Fail. 1995 Jul;17(4):467-74.
  • 49. • Rhabdomyolysis may be traumatic or non traumatic • Final common pathway of pathogenesis is the leak of intramuscular contents into circulation • Final common pathway is sequestration of Ca & H2O into muscles • Hallmark of AKI is ATN
  • 50. • Dipstick may be –ve for myglobinuria • Muscle pain may be absent • Re-rise of CK = Compartment syndrome or metabolic disorder • Corner stone of management is hydration
  • 51. • NaHCO3 = Precautions = Weak evidence • Mannitol = Precautions = Weak evidence • Ca supplement = Precautions • Prognosis is good